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DObjective: Mortality and morbidity related to right ventricular failure remain a problem for the long-term out-
come of congenital heart diseases. Therapeutic innovation requires establishing an animal model reproducing
right ventricular dysfunction secondary to chronic pressure-volume overload.
Methods: Right ventricular tract enlargement by transvalvular patch and pulmonary artery banding were created
in 2-month-old piglets (n ¼ 6) to mimic repaired tetralogy of Fallot. Age-matched piglets were used as controls
(n ¼ 5). Right ventricular function was evaluated at baseline and 3 and 4 months of follow-up by hemodynamic
parameters and electrocardiography. Right ventricular tissue remodeling was characterized using cellular electro-
physiologic and histologic analyses.
Results: Four months after surgery, right ventricular peak pressure increased to 75% of systemic pressure and
pulmonary regurgitation significantly progressed, end-systolic and end-diastolic volumes significantly increased,
and efficient ejection fraction significantly decreased compared with controls. At 3 months, the slope of the end-
systolic pressure-volume relationship was significantly elevated compared with baseline and controls; a signifi-
cant rightward shift of the slope, returning to the baseline value, was observed at 4 months, whereas stroke work
progressed at each step and was significantly higher than in controls. Four months after surgery, QRS duration
was significantly prolonged as action potential duration. Significant fibrosis and myocyte hypertrophy without
myolysis and inflammation were observed in the operated group at 4 months.
Conclusion: Various aspects of early right ventricular remodeling were analyzed in this model. This model
reproduced evolving right ventricular alterations secondary to chronic volumetric and barometric overload, as
observed in repaired tetralogy of Fallot with usual sequelae, and can be used for therapeutic innovation. (J Thorac
Cardiovasc Surg 2010;139:1197-204)Supplemental material is available online.Adult patients with congenital heart disease represent an
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The Journal of Thoracic and Carfollow-up, leading to impairment of functional status, severe
arrhythmia, and premature death.1,2 Current therapeutic
options for these patients are limited and show temporary
results.3 Moreover, studies evaluating the effects of usual
drugs on the right ventricle4 provide the emergent idea
that right ventricular (RV) adaptative pathways differ from
those of the left ventricle.5 Investigations and development
of new therapeutic approaches need to be pursued. To de-
velop therapeutic strategies to protect the right ventricle
against remodeling and prevent early morbidity and mortal-
ity, it is critical to create an animal model showing RV func-
tional and structural remodeling as observed in congenital
heart disease.
Among congenital heart diseases that result in long-term
RV failure, repaired tetralogy of Fallot (TOF) is one of the
most frequent. After a successful repair, favorable outcome
is normal, but the long-term course may be impaired by se-
vere ventricular arrhythmia and RV failure, which are conse-
quences of various postoperative RV sequelae.2 Pulmonary
regurgitation (PR), amplified by various degrees of residual
pulmonary artery branches stenosis,6 may create chronic
overload leading to RV function impairment.7 Moreover,
RV dilation often observed in these patients is linked todiovascular Surgery c Volume 139, Number 5 1197
Abbreviations and Acronyms
AP ¼ action potential
PR ¼ pulmonary regurgitation
PV ¼ pressure-volume
RV ¼ right ventricular
TOF ¼ tetralogy of Fallot
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Da QRS prolongation predicting malignant ventricular ar-
rhythmia and sudden death.8 Pulmonary valve replacement
may prevent RV failure, but the best timing for intervention
is still not well defined.9
The aim of this study was to establish an easily reproduc-
ible porcine model of repaired TOF mimicking the effects of
chronic RV overload. Hemodynamic, echocardiographic,
and electrocardiographic parameters were analyzed at 2 steps
of RV overload to follow the development of the disease. RV
tissue remodeling was assessed by cellular electrophysio-
logic and histologic techniques at the end of follow-up.MATERIALS AND METHODS
Experimental Design
Eleven Landrace male piglets, 47 to 87 days old (weight 15–25 kg), were
studied in accordance with the Guide for the Care and Use of Laboratory
Animals (National Institutes of Health, publication 85-23, revised in
1996). General anesthesia was performed with propofol 1%, allowing endo-
tracheal intubation, and maintained with isoflurane in 100% oxygen (Servo
900, Siemens-Elema AB, Solna, Sweden). Body length was measured from
the wither to the root of the tail. Body surface area and biological length
(square root of body surface area) were calculated. Peripheral oxygen satu-
ration and heart rate were monitored noninvasively throughout the proce-
dure.
Enlargement of the RV outflow tract was performed via a left thoracot-
omy. A side-biting vascular clamp was longitudinally placed across the pul-
monary valve annulus without obstruction of the RV outflow tract. A
pulmonary valve leaflet was excised, and the pulmonary infundibulum, an-
nulus, and trunk were enlarged by a 2-cm–long elliptically shaped polytetra-
fluorethylene patch to ensure loss of valve integrity. Pulmonary artery
banding, made of umbilical tape, was placed around the artery and secured
for a final diameter of approximately 1 cm (Figure E1).
Animals were studied at 3 experimental steps: baseline and 3 and 4
months of follow-up. Six animals were operated (operated group), and 5
age-matched animals were used as controls (control group). At each exper-
imental step, animals underwent electrocardiography, echocardiography,
and cardiac catheterization. In the operated group, baseline parameters
were recorded before surgery. Cellular electrophysiologic and histologic
studies were conducted after sacrifice at 4 months of follow-up.
Echocardiography
Transthoracic echocardiography was performed with a Hewlett-Packard
Sono 1500 echograph (Andover, Mass). The tricuspid/mitral diameters ratio
was calculated from tricuspid and mitral annulus diameters measured at the
maximal valve opening during diastole. The pulmonary annulus was mea-
sured at the maximal pulmonary valve opening during systole. The presence
of pulmonary stenosis or regurgitation was visualized using color Doppler
flow. Transpulmonary gradient through the pulmonary band was evaluated
by continued Doppler flow.1198 The Journal of Thoracic and Cardiovascular SurHemodynamic Study
Contractile performance of the RV was assessed by the conductance
catheter technique.10 Cardiac catheterization was performed through artery
and vein introducers placed through a cut-down. The reference cardiac out-
put was measured by using the transpulmonary thermodilution technique
(PiCCO system, Pulsion Medical Systems, Munich, Germany) to obtain
a systemic cardiac output reflecting the efficient pulmonary output indepen-
dently of the effect of PR; the mean of 3 consecutive recordings was re-
ported. After pressure calibration, a combined conductance-pressure
catheter (CD Leycom, Zoetermeer, The Netherlands) was inserted into the
RV apex and connected to a signal conditioner processor (Leycom
Sigma-5, CardioDynamics, Leyden, The Netherlands) to acquire an instan-
taneous RV volume signal processed on dedicated software (Conduct NT;
CD Leycom, Zoetermeer, The Netherlands). All recordings were corrected
in accordance with measured blood resistivity.10 Parallel conductance was
determined by the hypertonic 5% saline technique. Ventilation was arrested
during data collection. At least 10 pressure-volume (PV) loops were ac-
quired during cardiac output measurements with the PiCCO system to cal-
ibrate the stroke volume. The PV loops were recorded during 10 seconds of
apnea without intervention, and the basal state was assessed 5 minutes be-
fore occlusion maneuver. The PR fraction was measured from the PV loops
as the ratio between the PR volume and the total RV stroke volume.11 The
efficient stroke volume was calculated as the difference between the total
stroke volume and the measured volume of PR. The efficient ejection frac-
tion was calculated as the ratio between efficient stroke volume and end-di-
astolic volume. A balloon-tipped catheter (Tyshak 20 mm; NuMed Inc,
Hopkinton, NY) was inserted through the jugular vein, and its tip was situ-
ated just inferior to the right atrium for the purpose of abrupt alteration of
RV preload by vena cava occlusion. Series of PV loops were obtained for
each animal during the vena cava occlusion. The end-systolic PV relation-
ship describing the ventricular contractile status was examined during the
vena cava occlusion, and the slope of end-systolic PV relationship (Emax)
was computed.10
Electrocardiography
A 12-lead surface electrocardiogram was recorded and digitized by a Phi-
lips PageWriter Trim II cardiograph (Philips Medical Systems, Eindhoven,
The Netherlands). QRS duration was electronically measured on a 500-Hz
sample and defined as the maximal QRS length in any lead from the first in-
flection to the final sharp vector crossing the isoelectric line.
Cellular Electrophysiologic Study
Hearts were rapidly removed, and right ventricles were perfused by the
right coronary artery for 15 minutes with a modified cold Tyrode solution
containing (in millimoles per liter) 0.45 CaCl2, 2,3 butanedione monoxine,
and heparin 1250 UI/L. Right endocardial ventricular trabeculae were dis-
sected and bathed with Tyrode solution at 35 C containing (in millimoles
per liter) 120 NaCl, 5.6 KCl, 0.6 PO4H2Na, 24 CO3HNa, 1.1 MgCl2, 1.8
CaCl2, 10 glucose, 1.8 Na pyruvate, and 0.2 polyvinylpyrrolidone, and
gassed with 5% CO2 and 95% O2 (pH 7.4). Preparations were stimulated
at 1 Hz (pulse duration, 2–3 ms) and allowed to recover for 1 hour before
action potential (AP) recording by intracellular 3 M KCl microelectrodes
(15–30 MU). Resting membrane potential, AP amplitude, AP duration at
50% and 90% of repolarization, and maximum upstroke velocity of the
AP and AP area were determined at 4 months in both operated and control
groups.
Histologic Study
Tissue samples were collected after RV perfusion on the equatorial plane
fixed in 4% formalin and embedded in paraffin. Sections (3 mm thick) were
stained with Picrosirius red F3BA, Masson’s trichrome, orcein, hematoxy-
lin–eosin, or periodic-acid Schiff. Slides were examined at 203 magnifica-
tion, fields were recorded with an AxioCam MRc camera (Carl Zeiss,gery c May 2010
Lambert et al Congenital Heart Disease
C
H
DOberkochen, Germany), and analyses were conducted by 2 independent in-
vestigators. The interstitial collagen quantification was performed after Pic-
rosirius red coloration on 3 sections (10 fields/section) per animal and
expressed as a percentage of the total tissue.12 The myocyte diameter was
determined after Masson’s trichrome coloration by measuring the short
axis of 30 randomly chosen cells per field (30 fields per animal), and the
amount of myolysis was considered as severe if more than 25% of the sar-
comere was absent.
Statistical Analysis
Data were expressed as mean values  standard error of the mean. For
cellular electrophysiology and histology, average values for each parameter
in each animal were calculated. Groups were compared by 1-way analysis of
variance for repeated measurements, including post hoc analysis.RESULTS
Clinical Characteristics
During the post-surgery and post-catheterization periods,
all animals gained weight and showed no clinical signs of
heart failure. Delays after operation were 92  3 days at 3
months and 137  4 days at 4 months. Similar delays
were observed for the control group, 99 4 days at 3 months
and 133  4 days at 4 months. Populations were similar in
each group at each step in terms of age, weight, body surface
area, and biological length; heart rates decreased in time but
were similar for both groups (Table 1).Echocardiographic and Hemodynamic Data
On echocardiography, operated animals showed a marked
stenosis through the pulmonary banding: Maximal and mean
gradients through the pulmonary band were significantly el-
evated at 3 months without any change at 4 months (Table
1). In these animals, an important PR was detected by color
Doppler at 3 and 4 months, secondary to the significant en-
largement of pulmonary annulus diameter. The operated
group showed clear signs of a pronounced RV dilation, as
shown by the significant increase of tricuspid/mitral annulus
ratios at 3 months, persisting at the same level at 4 months
(Table 1). Conversely, the control group showed normal
echocardiographic parameters during the follow-up.
Quantification of barometric and volumetric overload de-
gree was performed by measuring intracardiac pressures
(Table 1) and RV volumes (Figure 1). The central venous
pressure was normal in both groups at each step. In the op-
erated group, RV end-systolic pressure increased signifi-
cantly at 3 months, remaining stable at 4 months; peak
pressure significantly increased to a level of 75% of sys-
temic pressure at 4 months; RV end-diastolic pressure pro-
gressed and was significantly higher than in the control
group at 3 and 4 months. The PR fraction was similar at
baseline in control and operated groups, 6.4%  4.5%
and 5.6%  3.4%, respectively; the PR fraction increased
progressively in the operated group and was significantly
higher than in the control group at 3 and 4 months (22.3%
 1.9% vs 4.6%  1.9%, respectively, P < .05 andThe Journal of Thoracic and Car25.0%  4.7% vs 3.0%  1.8%, respectively, P< .05).
End-systolic and end-diastolic volumes were markedly in-
creased in the operated group at 3 months and significantly
higher than in the control group at 4 months (Figure 1, A,
B), whereas efficient stroke volume progressed as in the con-
trol group (Figure 1, C). These results indicate a combined
barometric and volumetric RV overload consistent with
echocardiographic parameters.
In the operated group, the cardiac index was stable (Fig-
ure 1, D) and the efficient ejection fraction was significantly
decreased at 4 months (Figure 1, E), whereas the stroke work
clearly progressed at each step and was significantly higher
than in the control group at 4 months (Figure 1, F). More-
over, in the operated group, myocardial contractility as-
sessed by Emax showed a significantly elevated Emax at 3
months compared with baseline and the control group, sug-
gesting a positive change in inotropism. A significant right-
ward shift of Emax slope returning to the baseline value was
observed 4 months after surgery (Figure 2). No significant
variation of Emax was observed in the control group at the
different steps of follow-up.
QRS Duration and Cellular Electrical Properties of
the Right Ventricle
The mean QRS duration at baseline was similar in the op-
erated and control groups (58 3 ms and 61 3 ms, respec-
tively). The control group showed no significant variation in
QRS duration during the follow-up (68  5 ms and 72  6
ms at 3 and 4 months, respectively). In the operated group,
a significant prolongation of the mean QRS duration was ob-
served at 3 months (77 5 ms, P<.05 vs baseline) and was
slightly more at 4 months (81  4 ms, P< .05 vs baseline).
The evolution of QRS duration between the 2 groups with
time was significantly different.
At the cellular level, after 4 months of RV overload, AP
amplitudes, AP durations at 90% of repolarization, and
AP areas were significantly increased in the operated group,
whereas no differences in resting membrane potential and
maximum upstroke velocity of AP were observed (Table 2).
Right Ventricular Tissue Remodeling
Four months after surgery, a collagen accumulation was
detected in interstitial spaces and between fiber bundles
(20.7%  10.3% vs 13.4%  5.5% in control group,
P< .001), whereas the control group showed narrow myo-
cytes, well-aligned and surrounded by thin interstitial tissues
(Figure 3, A, B). No elastic fibers were identified between
myocytes in both groups (Figure 3, C, D). In the operated
group, myocytes were significantly enlarged (18.3  4.4
mm vs 14.3  2.9 mm in the control group, P< .001),
whereas no intracellular myolysis was observed (Figure 3,
E, F). No inflammation and glycogen granules were detected
(data not shown), suggesting a partial remodeling of the RV
tissue.diovascular Surgery c Volume 139, Number 5 1199
TABLE 1. Population characteristics, echocardiography data, and intracardiac pressures in control and operated groups at each step of
experimentation
Follow-up
Baseline At 3 months At 4 months
Group Control
n ¼ 5
Operated
n ¼ 6
Control
n ¼ 5
Operated
n ¼ 6
Control
n ¼ 5
Operated
n ¼ 6
Population characteristics
Age (d) 64.4  7.3 71.5  1.2 162.0  7.7* 163.8  3.7* 193.6  6.8*,z 206.8  3.2*,z
Weight (kg) 18.3  1.9 18.9  1.1 41.4  4.2* 45.2  4.2* 47.1  4.4*,z 56.8  3.0*,z
Body length (cm) 61.6  2.8 64.5  1.3 80.4  2.2* 84.8  3.0* 84.4  3.1*,z 91.3  1.8*,z
Body surface area (m2) 0.56  0.04 0.58  0.02 0.96  0.06* 1.03  0.07* 1.05  0.07*,z 1.20  0.04*,z
Biological length (m) 0.74  0.03 0.76  0.01 0.98  0.03* 1.01  0.04* 1.02  0.03*,z 1.10  0.02*,z
Heart rate (beats/min) 122  11 135  8 102  7* 106  6* 97  12*,z 90  4*,z
Echocardiographic data
Ratio T/M diameters 0.80  0.05 0.75  0.03 0.84  0.03 1.16  0.06*,y 0.77  0.04 1.20  0.05*,y
PA annulus diameter/L (mm) 16.9  0.8 16.8  0.4 17.4  0.7 21.3  1.3*,y 16.2  0.9 21.3  0.9*,y
RV/PA maximal gradient (mm Hg) 2.0  0.4 2.4  0.2 2.5  0.4 44.7  9.5*,y 2.2  0.3 45.6  11.7*,y
RV/PA mean gradient (mm Hg) — — 1.4  0.2 28.9  6.2y 1.2  0.2 30.1  8.2y
Intracardiac pressures
Mean aortic blood pressure (mm Hg) 70.0  5.1 65.8  7.4 74.4  6.7 76.5  4.7 69.8  4.3 62.7  4.9
Systolic aortic blood pressure (mm Hg) 86.0  5.4 83.7  8.5 91.0  6.6 97.7  3.9 86.8  4.3 84.5  4.9
Central venous pressure (mm Hg) 1.8  0.6 2.7  1.1 1.6  0.7 3.8  1.1 2.2  0.5 4.0  1.4
RV pressure (mm Hg)
Peak 20.4  1.2 16.8  1.2 15.8  0.8 63.8  11.4*,y 16.4  0.9 63.7  10.7*,y
End systolic 12.6  1.0 11.5  0.8 7.4  0.7 54.8  10.6*,y 8.0  1.6 53.8  10.1*,y
End diastolic 1.6  0.6 1.7  1.1 1.4  1.4 6.0  1.2*,y 1.4  0.7 5.8  1.7*,y
Ratio systolic pressure RV/aorta (%) 24  2 21  2 18  2 68  14*,y 19  1 76  12*,y
L, Biological length (square root of body surface area); M, mitral; PA, pulmonary artery; RV, right ventricle; T, tricuspid. *P<.05 versus corresponding group at baseline. yP<.05
operated group versus control group at the same step. zP< .05 corresponding group at 4 months versus 3 months.
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DDISCUSSION
We have characterized an experimental model of chronic
RV PV overload, as observed in congenital heart diseases,
leading to the first stage of RV remodeling and applicable
for therapeutic innovation.
Our study is the first to describe the various aspects of RV
function in a large animal model, including hemodynamic,
electrical, and histologic anomalies, in the presence of
chronic PV overload. Among congenital heart diseases re-
sulting in RV failure in the long term, TOF is the most fre-
quent. The surgical technique, mimicking repaired TOF, is
easily performed by experienced cardiac congenital sur-
geons and reproduces anomalies that are clinically observed
at long term, including RV dilatation, QRS prolongation,
RV function impairment, and structural changes. This model
allows innovative therapeutic tests and determination of the
best timing of intervention to treat RV tract diseases.9 Other
studies conducted on experimental models of RV chronic
overload mainly analyzed the hemodynamic effects on RV
function13-15 and demonstrated a myocardial adaptation
within an overload period of no more than 3 months.14,15
Thus, a longer period of observation seemed necessary to de-
tect the RV remodeling and the first stage of dysfunction. In
our study, the follow-up was more than 3 months, and final1200 The Journal of Thoracic and Cardiovascular SurRV functional and structural analyses were performed 4
months after surgery.
This experimental model was created using the surgical
procedure described by Zelster and colleagues.13 Our model
showed a significant enlargement of the pulmonary annulus
area and a marked PR. A pulmonary artery band added to
create a mild pulmonary stenosis elevated RV peak pres-
sures up to 75% of systemic pressure at the end of follow-
up, as observed in patients with the most severe sequelae.
This pulmonary banding, simulating the pulmonary branch
stenosis observed in some patients after TOF repair, was per-
formed downstream to the infundibulo-ventricular patch to
amplify the PR as described by Chaturvedi and collabora-
tors.6 One consequence of PR is a marked volumetric over-
load, despite the large variability of both end-systolic and
end-diastolic volumes observed between each animal in
the 2 groups. This inter-animal variability of volumes mea-
sured with a catheter-conductance technique was also ob-
served in another porcine model, indicating a possible
relation to the complex geometry of the RV chamber.10
The combined PV RV overload, secondary to this combina-
tion of pulmonary stenosis and regurgitation, tends to accel-
erate the RV dysfunction, as observed in both experimental
and clinical situations.13,16gery c May 2010
0
1
2
3
4
5
6
7
8
baseline 3m 4m
Ca
rd
ia
c 
in
de
x 
(m
l/m
in
/m
²)
D
0
50
100
150
200
250
300
350
baseline 3m 4m
 
ES
V 
(m
l)
A
*
*
0
50
100
150
200
250
300
350
400
450
baseline 3m 4m
ED
V 
(m
l)
B
*
*
*
0
20
40
60
80
100
120
140
baseline 3m 4m
eS
V 
(m
l)
C
*
*
0
1000
2000
3000
4000
5000
baseline 3m 4m
SW
 
(m
l.m
m
H
g)
F
*
*
*
0
10
20
30
40
50
60
70
baseline 3m 4m
eE
F 
(%
)
E
*
*
*
FIGURE 1. Hemodynamic parameters issued from PV loop measurements. Evolution of RV volumes (upper): end-systolic volume (A), end-diastolic vol-
ume (B), efficient stroke volume (C). Incidence of RV chronic overload on (lower) cardiac index (D), efficient ejection fraction (E), and stroke work (F).
Values at baseline, 3 months, and 4 months in operated (black, n ¼ 6) and control (white, n ¼ 5) groups are plotted as mean  standard error of the
mean. *P< .05.
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to reproduce RV dysfunction. In regard to the RV myocar-
dial contractility, Emax changes differed according to the ob-
servation period in the operated group. At 3 months, Emax
reached to the left and above the baseline, implying a positive
inotropic change. This enhanced contractility corresponds
with an increased RV contractility in the presence of acutely
or chronically increased RV afterload described earlier.14,15
These studies suggested the RV homeometric autoregulation
as an important adaptation to RV pressure overload.15 A
challenge was to identify the turning point from compen-
sated hypertrophy to RV failure. At 4 months, a significant
rightward shift of Emax returning to the baseline value was
observed. This negative change in inotropism may be inter-
preted as normalization after the adaptation period because
of the homeometric regulation. Conversely, the change
may be considered as the first step of RV remodeling toward
dysfunction because the RV overload was maintained. In
support of this hypothesis, Kuehne and colleagues17 found
that RV myocardial reserve and contractility were impaired
after 3 months of evolution in a model of isolated PR and
that the systolic pump performance was decreased similarly
as observed in PR associated with pulmonary stenosis.14,17
In accordance with these findings, the efficient ejection frac-
tion decreased and the cardiac index failed to appropriately
increase in the operated group, despite the elevation of
volumes and incremental stroke work. This suggests that
the adaptative response to pathologic loading conditions is
not sufficient and that the homeometric effects of pressure
overload are transitory.The Journal of Thoracic and CarThe late contractility decrease was associated with struc-
tural changes: Cardiomyocyte diameters and fibrosis rate
were significantly increased in the operated group. This
remodeling, previously described in other experimental
RV overloaded models, seems to result from regional
overexpression of growth factors.18,19 Moreover, cellular
hypertrophy was also found in both RV pressure- and vol-
ume-overloaded models, and in patients with repaired
TOF.18,20 Conversely, fibrosis was observed only in the
pressure-overloaded model, with a possible link between
diminished anatomic coronary vascular reserve and connec-
tive tissue proliferation.18 In our model, it seems difficult to
relate fibrosis to pulmonary stenosis rather than PR in anal-
ogy to the human pathology. Although histologic studies
were not reported for a long time after TOF repair, magnetic
resonance imaging, performed in adult patients with isolated
severe PR and RV dilatation, detected fibrosis related to im-
paired ventricular dysfunction and clinical arrhythmia.21
Our histologic findings are in agreement with these results
and confirm the link between structural changes and func-
tional abnormalities. We can postulate that mechanisms
inducing progressive fibrosis are associated with ventricular
dilatation and hypertrophy resulting from PR or stenosis that
leads to adverse RV remodeling. The absence of myolysis,
glycogen granules, and elastic fibers corroborates with the
hypothesis that the RV dysfunction has just begun, and the
process may be reversible if residual RV tract anomalies
are treated or therapies are applied.16
The RV myocardial contractility impairment and tissular
remodeling are consistent with the cellular electrophysiologydiovascular Surgery c Volume 139, Number 5 1201
FIGURE 2. Emax variation during follow-up: Representative PV loops and corresponding Emax recorded in control (A) and operated (B) groups at baseline
(dotted line), 3 months (dashed line), and 4 months (solid line). Note the marked increase of volume over time in the operated group. (C) Emax mean values
standard error of the mean from 6 operated and 5 control animals at baseline (dotted), 3 months (hatched), and 4 months (black). *P< .05.
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pecially action potential duration at 90% of repolarization.
These modifications are usually encountered in hypertrophic
and failed myocardia,22 and correspond to the repolarization
dispersion found in patients late after TOF repair.23 In these
patients, a depolarization in homogeneity conveyed by
a QRS prolongation is also observed23 as the result of RV
outflow tract abnormalities24 and diffuse RV myocardial
anomalies.25 Prolongation of QRS is recognized as a major
risk for severe ventricular arrhythmias and responsible for
an increased risk of sudden death.8 Recent studies demon-
strated a mechanoelectrical interaction and a direct relation-
ship among QRS duration, RV size, and function in
patients and an experimental model.8,13 This is consistent
with the significant QRS prolongation found in our operated
group. Because QRS prolongation is considered as a marker
of prognosis strongly related to RV function,8 this parameterTABLE 2. Right ventricular action potential parameters in control
and operated groups
Group Control
n ¼ 3
Operated
n ¼ 5
Cell no. 104 198
MP (mV) 76.4  0.7 76.2  0.5
AP amplitude (mV) 93.6  1.1 98.2  0.7*
Vmax (V/s) 148.4  12.3 128.2  8.8
APD 90% (ms) 260.5  3.1 295.0  4.8*
AP area (mV/ms) 17,727  370 21,599  413*
MP, Membrane potential; AP, action potential; Vmax, maximum upstroke velocity of
the AP ascending phase; APD 90%, action potential duration at 90% of repolarization.
*P< .05.
1202 The Journal of Thoracic and Cardiovascular Surmay contribute to the evaluation of the RV remodeling in ex-
perimental therapeutic studies.CONCLUSIONS
We have established and characterized an experimental
porcine model of repaired TOF leading to RV dysfunction
secondary to chronic combined PV overload that is applica-
ble for therapeutic innovation and determination of the best
timing of intervention.9 Moreover, in several other congen-
ital heart diseases, the RV, being the dominant or systemic
ventricle, sustains systemic overload and develops long-
term dysfunction. Therefore, this model may contribute to
the study of RV failure occurring in other types of congenital
heart involving chronic RV PV overload. RV failure occurs
in young adult patients a long time after TOF repair,2 but the
impairment of overloaded RV contractility exists long be-
fore heart failure signs become evident.17 Our study de-
scribes RV remodeling diseases at an early stage and may
help to identify a parameter in the timing of RV dysfunction
evolution to test therapeutics that will prevent RV failure.
Therapeutic studies may be initiated with innovating con-
cepts such as cell therapy. The effects on the different as-
pects of RV failure, best timing of treatment, and optimal
modalities of administration should be evaluated.
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FIGURE 3. Tissue sections from control (A, C, E) and operated (B, D, F) animals after Picrosirius red (A, B), orcein (C, D), and Masson’s trichrome (E, F)
staining at 4 months. Bar¼ 50 mm. No elastic fibers were observed in both groups outside of vessels (inserts C, D). Higher magnification (inserts E, F) shows
absence of myolysis but myocyte hypertrophy in operated animals. Bar ¼ 20 mm.
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FIGURE E1. Two major steps of the surgical procedure: Enlargement of right ventricular (RV) outflow tract was performed via left thoracotomy. Side-
biting vascular clamp was longitudinally placed across the pulmonary valve annulus without obstruction of the RV outflow tract (A). Pulmonary valve leaflet
was excised, and pulmonary infundibulum, annulus, and trunk were enlarged by a 2-cm–long elliptically shaped polytetrafluorethylene patch to ensure loss of
valve integrity. Pulmonary artery banding, made of umbilical tape, was placed around the artery and secured for a final diameter of approximately 1 cm (B).
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